F.T.C. Settles With Express Scripts Over High Insulin Pricesnews2026-02-04T21:40:27+00:00February 4th, 2026|The New York Times|
Eli Lilly, Drug Maker of Zepbound and Mounjaro, Reaches $1 Trillion in Valuenews2025-11-21T21:25:40+00:00November 21st, 2025|The New York Times|
People With Severe Diabetes Are Cured in Small Trial of New Drugnews2025-06-20T23:38:23+00:00June 20th, 2025|The New York Times|
Trump Seeks to Lower Drug Prices Through Medicare and Some Importsnews2025-04-16T15:13:36+00:00April 16th, 2025|The New York Times|
Insulin Prices Dropped. But Some Poor Patients Are Paying More.news2025-01-16T10:00:13+00:00January 16th, 2025|The New York Times|
Pfizer Stopped Us From Getting Ozempic Decades Agonews2024-12-25T23:11:22+00:00December 25th, 2024|The New York Times|
On Drug Prices, Harris Pushes for Deeper Cuts While Trump Offers Few Specificsnews2024-10-08T17:07:01+00:00October 8th, 2024|The New York Times|
F.T.C. Accuses Drug Middlemen of Inflating Insulin Pricesnews2024-09-20T19:16:14+00:00September 20th, 2024|The New York Times|
Hot Summer Threatens Efficacy of Mail-Order Medicationsnews2024-08-13T14:04:23+00:00August 13th, 2024|The New York Times|
South Africa Runs Out of Insulin Pens as Global Supply Shifts to Weight-Loss Drugsnews2024-06-19T09:02:12+00:00June 19th, 2024|The New York Times|
